Status:
COMPLETED
Assessment of the Prevalence of Sarcopenia in Early Palliative Cancer Patients
Lead Sponsor:
Weprom
Conditions:
Metastatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Cancer is one of the leading causes of death in the world after cardiovascular disease (8.7 million deaths in 2015 for 17.5 million cases) 1. Despite a great deal of progress in disease detection and ...
Eligibility Criteria
Inclusion
- age\> 18 years old,
- patient with solid cancer diagnosed with metastatic disease,
- having had a biological assessment and a CT scan in the month preceding the medical consultation,
- and whose prognosis is considered palliative
Exclusion
- age \<18 years old,
- adults under guardianship measure,
- pregnancy or breastfeeding in progress,
- malignant hemopathies,
- metastatic germ cell tumors,
- non-metastatic disease
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04714203
Start Date
June 1 2019
End Date
August 31 2019
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Victor Hugo / Centre Jean Bernard
Le Mans, France, 72000